Coya Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Coya Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Coya Therapeutics Inc
Rating: 1.46566675
Author: Trendlyne DVM scores

about

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...

6.13 -0.19 (-3.01%)

40.14% Fall from 52W High

74,445

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.2 / 100

Technically Neutral

51.5 / 100

1Yr Price target upside is 171%

7 analysts

Coya Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coya Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...

40.14% Fall from 52W High

SWOT Analysis

Coya Therapeutics Inc Live Price Chart